Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-02-23

Clinical Trial Update: A Phase 4, Single-Blind, Randomized, Study to Compare the Tolerability and Efficacy of 0.1% Tazorac Cream When Used in Combination With Either Duac Gel or Acanya Gel for the Treatment of Facial Acne Vulgaris [Phase 4]

View source ↗

Summary

A Phase 4, single-blind, randomized trial evaluating the tolerability and efficacy of tazarotene 0.1% cream used with either Duac Gel or Acanya Gel for facial a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acanya Gel (benzoyl peroxide 2.5% + clindamycin phosphate 1.2% topical)
  • Duac Gel (benzoyl peroxide/clindamycin)
  • Tazorac Cream 0.1% (tazarotene)

Snippet

Sponsor: Stiefel, a GSK Company | Conditions: Acne Vulgaris | Phase 4 | Status: COMPLETED | Results posted: 2012-02-23